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Abstract
As pattern recognition receptor on dendritic cells (DCs), DC-SIGN binds carbohydrate structures on its pathogen ligands
and essentially determines host pathogen interactions because it both skews T cell responses and enhances pathogen
uptake for cis infection and/or T cell trans-infection. How these processes are initiated at the plasma membrane level is
poorly understood. We now show that DC-SIGN ligation on DCs by antibodies, mannan or measles virus (MV) causes rapid
activation of neutral and acid sphingomyelinases followed by accumulation of ceramides in the outer membrane leaflet.
SMase activation is important in promoting DC-SIGN signaling, but also for enhancement of MV uptake into DCs. DC-
SIGN-dependent SMase activation induces efficient, transient recruitment of CD150, which functions both as MV uptake
receptor and microbial sensor, from an intracellular Lamp-1+ storage compartment shared with acid sphingomyelinase
(ASM) within a few minutes. Subsequently, CD150 is displayed at the cell surface and co-clusters with DC-SIGN. Thus, DC-
SIGN ligation initiates SMase-dependent formation of ceramide-enriched membrane microdomains which promote
vertical segregation of CD150 from intracellular storage compartments along with ASM. Given the ability to promote
receptor and signalosome co-segration into (or exclusion from) ceramide enriched microdomains which provide a
favorable environment for membrane fusion, DC-SIGN-dependent SMase activation may be of general importance for
modes and efficiency of pathogen uptake into DCs, and their routing to specific compartments, but also for modulating T
cell responses.
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Introduction
Their interaction with myeloid dendritic cells (DCs) is believed to
be central to the understanding of immunomodulation by viruses
also including measles virus [1,2,3,4]. In the hematopoetic system,
MV replication segregates with expression of CD150, an Ig-like
domain containing molecule, expression of which is usually low on
lymphocytes and immature DCs, where it is upregulated on
activation by TLR ligation or inflammatory stimuli [5,6,7]. CD150
is sufficient to support MV binding, fusion and cell entry in vitro and
in vivo [8]. In DCs, in common with other viruses, DC-SIGN
enhances entry, and this is important in viral spread to secondary
lymphatics and transmission to T cells, but also for modulation of
DC viability and function and thereby determine T cell activation in
quantitative and qualitative terms [9,10,11,12,13].
DC-SIGN is a C-type lectin receptor which functions to
regulate adhesion by interaction with integrins, but also, as a
pattern recognition receptor (PRR), to recognize carbohydrate
structures on pathogens, thereby targeting them for endocytic
uptake, processing and subsequent presentation [13,14,15]. It is
enriched in nanoclusters at the leading edge on the DC plasma
membrane, where ligands are acquired and then transported
rearward to mid-lamellar sites for subsequent endocytosis
[16,17,18,19]. On differential recognition of carbohydrates, DC-
SIGN signals and its signalosome involves a scaffolding complex
containing lymphocyte specific protein 1 (LSP1), kinase suppressor
of Ras1 (KSR1) and connector enhancer of ksr (CNK) as required
for Raf-1 recruitment [20]. DC-SIGN-induced Raf-1 kinase
activation was linked to modulation of TLR signaling at the level
of NF-kB activation by promoting activation of its p65 subunit and
thereby increasing initiation and duration of cytokine gene
transcription [11,21,22].
By unknown mechanisms, viruses can escape lysosomal
degradation thereby avoiding immune surveillance, and rather
exploit DC-SIGN to gain entry to DCs [12,13,23,24]. Similarly,
how DC-SIGN enhances viral uptake for infection (referred to as
’cis-infection’) or internalization into and storage in non-lysosomal
compartments for subsequent transfer to conjugating T cells
(referred to as ‘trans-infection’) is mechanistically not well
understood, however, co-segregation or concentration of virions
or their respective low level expressed uptake receptors has been
proposed to contribute [1,25].
Local enrichment of ceramides is known to promote biophysical
alterations of the membrane which can support fusion and
negative curvature, but also segregation of membrane receptors
and signalosome components thereby regulating a large variety of
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cellular processes [26,27,28,29]. In response to a variety of stimuli
also including ligation of TNF-R family members and Fcc
receptors, neutral and acid sphingomyelinases (SMases: NSM or
ASM) are activated to generate membrane ceramides, which, on
ASM activation, cause formation of outer membrane ceramide–
enriched platforms [30,31,32]. In contrast to NSM, ASM is
compartimentalized in non-lysosomal vesicles from where, on
activation, it is recruited to the cell surface to catalyze breakdown
of sphingomyelin (SM) into phospho-choline and ceramide.
Ceramides act to convey and modulate receptor signaling by
segregating or concentrating signaling components and this also
includes KSR1, which catalyzes c-Raf-1 activation thereby
enhancing its activity towards ERK1/2 [33,34,35,36,37]. As they
promote receptor clustering and formation of membrane invag-
inations, ceramides can enhance endocytic uptake of viruses
entering their target cells by this route [38,39]. Ceramides can,
however, also enhance intracellular vesicle fusion [40]. Thus,
regulation of lateral segregation and concentration of receptors by
ceramide-enriched platforms (or interference with that, as
evidence for HIV [40] and of membrane fusion may be key to
understanding the role of ceramides in viral uptake.
We now show that DC-SIGN ligation causes transient
activation of both NSM and ASM within 3 to 15 mins. and this
is accompanied by membrane ceramide accumulation. DC-SIGN
signaling accounting for c-Raf-1 and ERK activation is abrogated
on pharmacological interference with ASM activation indicating
that activation of this enzyme is essential in this process. SMase
activation also accounted for enhancement of MV uptake into
DCs and this was promoted by DC-SIGN dependent surface
recruitment of the MV binding and uptake receptor CD150,
which was surface recruited from an intracellular storage
compartment containing ASM. These data, for the first time,
describe and mechanistically link regulated membrane lipid
dynamics to modulation of PRR-dependent uptake into DCs,
which may be relevant for viral and general entry processes into
these cells.
Results
DC-SIGN ligation promotes ceramide accumulation on
DCs in a SMase-dependent manner
Membrane ceramide platforms segregate receptors and signalo-
somes both of which can affect viral entry. DC-SIGN may act to
trap or concentrate virions (also including MV) for receptor
interaction, and we thus analysed whether MV interaction with
this molecule promoted membrane ceramide accumulation on
DCs by employing an assay based on immunodetection of an a-
ceramide antibody bound to intact cells (spot assay). On MV
exposure, DCs responded by an about twofold increase in
extrafacial ceramides which peaked at 15 mins and subsequently
returned to baseline levels (Fig. 1A, left panel). Ceramide
accumulation occurred DC-SIGN dependently, since it was
efficiently abrogated upon pre-exposure of DCs with a DC-
SIGN-specific antibody (AZ-D1) or EGTA, which prevents Ca2+-
dependent DC-SIGN ligand binding (Fig. 1A, left panel and
middle panel). In contrast, antibodies blocking MV interaction
with its entry receptor, CD150, did not prevent, yet even slightly
enhanced MV ceramide induction (Fig. 1A, right panel). Similar to
MV, the DC-SIGN binding antibody AZ-D1 increased membrane
ceramide display when crosslinked, while this was not observed
with the antibody alone nor an isotype control antibody alone
(Fig. 1B, left panel; for further experiments, DC-SIGN-specific
antibodies were thus used crosslinked). Ceramide production in
response to DC-SIGN ligation was sensitive to the ASM inhibitor
amitriptyline indicating that activation of this enzyme was
involved (Fig. 1B, right panel). To assess activation of SMases
directly, we determined their activity after exposure of DCs to
mannan, a well-defined DC-SIGN agonist. In line with amitrip-
tyline sensitivity of ceramide generation, ASM surface display
raised about 1.8 fold almost immediately following mannan
addition, and this was paralleled by a rise in extrafacial ceramides
both of which were EGTA sensitive (Fig. 1C, and not shown).
Mannan-dependent activation of ASM was further confirmed
using a commercial detection assay (Fig. 1D, left panel) which
essentially mirrored kinetics and magnitude of the response
determined by spot assays. Using the same experimental
approach, a rapid, very efficient activation of NSM was also
measured (about 5-fold) which peaked after 3 mins and then
vanished, and this was entirely prevented upon RNAi mediated
silencing of NSM expression (Fig. 1D, right panel). Importantly,
ASM activation also occurred on MV exposure of DCs in a dose
dependent manner, and this relied on the presence of the MV
glycoproteins because it was not observed when a recombinant
MV expressing the VSV G protein instead was used (Fig. 1E).
Altogether these findings indicate that ligation of DC-SIGN by
antibodies, mannan or MV promotes rapid activation of SMases,
and ASM-dependent ceramide accumulation in the outer
membrane leaflet.
ASM activation is essential for DC-SIGN signaling
DC-SIGN signaling includes activation of c-Raf-1 and ERK
[11,22,41]. To asses if DC-SIGN signaling involves SMase
activation, cells were pre-exposed to amitriptyline which per se
did not affect DC viability (not shown) or LPS-induced upregula-
tion of CD86 or CD83 after 24 hrs (Fig. 2A). PMA/ionomycin-
dependent activation of c-Raf-1 or ERK as determined by
detection of p-c-Raf-1 or pERK within 30 mins was unaffected
on pre-exposure of DCs to amitriptyline (Fig. 2B, upper panels). In
line with earlier findings obtained upon ManLam-, antibody or
HIV exposure [11,22,41], DC-SIGN ligation by crosslinked AZ-
D1 caused c-Raf-1 and ERK activation (Fig. 2B, bottom panels).
Author Summary
Dendritic cells (DCs) bear receptors specialized on
recognition of patterns specific to pathogens (such as
carbohydrates), which can either promote functional
activation of these cells (such as TLRs), which renders
them capable of efficiently presenting antigens to T cells,
or, as DC-SIGN, endocytic uptake as essential for loading
MHC molecules. Viruses such as HIV and measles virus (MV)
exploit DC-SIGN for both their uptake into DCs and
modulation of TLR signaling, yet how this is mechanisti-
cally exerted is poorly understood. We now show that DC-
SIGN activates sphingomyelinases (SMases) which convert
their sphingomyelin substrate into ceramides, thereby
catalysing the formation of membrane platforms able to
recruit and concentrate receptors and associated signaling
components. We found DC-SIGN-dependent SMase acti-
vation as essential for DC-SIGN and thereby modulation of
TLR signaling, but also for enhancement of MV uptake.
This is mediated by a fast, transient recruitment of its entry
receptor, CD150, from an intracellular storage compart-
ment to the cell surface where it co-clusters in ceramide
enriched platforms with DC-SIGN. The ability to segregate
viral receptors into (or exclude them from) membrane
microdomains, which, based on their biophysical proper-
ties, facilitate membrane fusion, proposes DC-SIGN-medi-
ated SMAse activation as a central regulator of pathogen
uptake into DCs.
DC-SIGN Mediated SMase Activation
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In contrast to that induced by PMA/ionomycin, however, a-DC-
SIGN induced c-Raf-1 and ERK phosphorylation was sensitive to
amitriptyline indicating that DC-SIGN signaling involves ASM
activation (Fig. 2B, bottom panels). DC-SIGN signaling does not
confer NF-kB activation, yet apparently modulates that induced
upon TLR ligation [11]. As revealed both by an ELISA kit based
detection system or nuclear translocation of p65, TLR4 ligation by
LPS indeed promoted NF-kB activation after 60 mins. (Fig. 3A).
Mannan exposure did, however, reduce magnitude of NF-kB
activation measured by either method indicating that DC-SIGN
ligation interferes with TLR4 signaling (Fig. 3A and B).
Interestingly, however, ablation of DC-SIGN signaling by
amitriptyline or an NSM inhibitor, GW4896, apparently en-
hanced LPS-induced NF-kB activation as reflected by efficient
nuclear accumulation of p65, and enhanced levels of activation as
determined by ELISA (Fig. 3B and C). Overall, these findings
support the interpretation that DC-SIGN membrane signaling
essentially involves ceramide generation, and may act to dampen
rather than to enhance TLR-dependent NF-kB activation and
thereby production of pro-inflammatory cytokines.
SMase activation enhances MV infection of DCs
To assess the overall impact of SMase activation on MV uptake
into DCs, these were exposed to amitriptyline prior to infection.
Thereby, intracellular accumulation levels of MV N protein 12 hrs
following infection were reduced by about 50% (Fig. 4A, left panel)
indicating that SMase activation is beneficial for viral DC infection.
Consistent with this hypothesis, GFP levels produced from a tagged
MV wild-type recombinant virus only on replication (IC323-eGFP)
were reduced by about 50% upon siRNA mediated ablation of
ASM expression (Fig. 4A, right panel). Pre-exposure to amitriptyline
did not affect MV binding to DCs as determined by detection of
MV F protein positive cells after 2 hrs at 4uC (Fig. 4B, left panel and
graph), yet efficiently reduced intracellular GFP-accumulation after
24 hrs (with FIP added following infection to prevent MV spread)
(Fig. 4B, right panel and graph). Amitriptyline did, however, not
affect uptake or replication of a recombinant attenuated MV strain
into T or epithelial cells (Fig. 4C) (which cannot be infected with
IC323-eGFP due to the absence of CD150) indicating that SMase
activation or ceramide elevation alone do not necessarily enhance
MV infection as occurring in DCs.
Figure 1. DC-SIGN ligation activates SMases and causes membrane ceramide accumulation on DCs. A. to C. Surface ceramide levels on
DCs were determined by spot assays (shown in the insets) or flow cytometry (A, B). A. DCs were exposed to a MOCK preparation (open circles left
panel), MV alone (black circles, left and middle panels) or after pretreatment with a blocking DC-SIGN antibody (AZ-D1) (black triangles, left panel) or
in the presence of EGTA (open circles, middle panel). Right panel: DCs were left untreated (black circles) or exposed to an aCD150-antibody (5C6)
prior to MV or MOCK treatment (white circles and black triangles, respectively). B. DCs were exposed to AZ-D1 alone (open circles, left panel) or after
addition of a crosslinking antibody (filled circles, both panels). DCs were stimulated with isotype antibody as a negative control (black triangles, left
panel) or DC-SIGN was ligated after 2 hrs pretreatment with amitriptyline (open circles, right panel). C. DCs were exposed to mannan for the time
intervals indicated and surface levels of ASM (black triangles) and ceramides in the absence (black circles) or presence of EGTA (open circles) were
analysed by spot assays (left panel). D. Whole cell lysates (for ASM, left panel) or membrane fractions (for NSM, right panel) of DCs exposed to
mannan for the time intervals indicated were used to determine enzyme activities using a commercial kit. DCs were transfected with NSM siRNA
(open circles) or not (black circles) (right panel, with effciency of NSM ablation shown by RT-PCR in the inset). E. ASM activity was determined 10 mins
following exposure of DCs to MV or a recombinant MV expressing VSV G protein instead of the MV glycoproteins (MGV) at the multiplicities of
infection indicated or a mock preparation applied at a concentration corresponding to m.o.i 2) as in D. Experiments shown are representatives of
each three independent experiments involving different donors.
doi:10.1371/journal.ppat.1001290.g001
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Figure 2. ASM activity is essential for DC-SIGN signaling. A. Surface expression levels of CD83 and CD86 were determined on DCs left untreated
(iDCs, white bars) or pre-exposed to amitriptyline (black bars) or not (grey bars) prior to LPS stimulation (mDCs) after 24 hrs by flow cytometry. B. Levels
of p-c-Raf1 and p-ERK were determined in DCs left untreated (right graphs: each black circles) or exposed to amitriptyline for 2 hrs (right graphs: each
open circles) and subsequently activated by PMA/ionomycin (upper panels and right graphs, obtained after densitometric quantification) or AZ-D1
(followed by crosslinking) for the time intervals indicated (bottom panels and right graphs). ERK detection served as loading control.
doi:10.1371/journal.ppat.1001290.g002
Figure 3. SMase dependent DC-SIGN signaling dampens rather than enhances TLR-stimulated NF-kB activation. A. NF˜kB activation in
DCs activated by LPS alone (white bars) or in the presence of mannan (black bars) was determined by measuring DNA binding using an ELISA based
kit (left panel) or by determining the percentage of cells translocating p65 to the nucleus (right panel; 100 cells per treatment were recruited into the
analysis, for an example see 3C) after the time intervals indicated. B. NF˜kB activation in DCs exposed LPS alone (white bars) or together with mannan
only (left panels, black bars) or after a 2 hrs pretreatment with amitriptyline (left panel, light grey bars) or to GW4869 (left panel, dark grey bars) was
analysed by determining the percentage of cells translocating p65 to the nucleus (each 150 cells per treatment were recruited into the analysis), or in
DCs left untreated (right panel dark grey bar) or activated for one hour by LPS alone (right panel, white bar) or together with AZ-D1 (followed by
crosslinking) only (right panel, black bar) or after a 2 hrs pre-treatment with amitriptyline (right panel, light grey bar) by measuring p65 DNA binding
by ELISA. C. Representative images showing examples for scoring into nuclear and cytoplasmic localization as evaluated in A and B. Upper left panel:
2LPS, upper right and bottom left panels: +LPS, lower right panel: ami +LPS. Cells were counterstaining by phalloidin (mainly detecting cortical f-
actin lining the plasma membrane) and DAPI. Data shown in A–C represent each one representative out of three independent experiments.
doi:10.1371/journal.ppat.1001290.g003
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DC-SIGN signaling promotes CD150 surface recruitment
MV binding to DC-SIGN causes SMase activation on DCs
which, in turn, promotes MV infection. We thus analysed whether
this might relate to DC-SIGN-dependent alterations of membrane
distribution of CD150. Because expression levels of this protein are
low on DCs ([9,10] and see below), we initially analysed the impact
of DC-SIGN ligation on CD150 expression in Raji cells expressing
high levels of endogenous CD150, and on stable transfection, DC-
SIGN (Raji-DC-SIGN) (Fig. 5A, upper and second row). In
untreated Raji-DC-SIGN cells, both molecules revealed a
punctate expression pattern overall covering the cell surface
(Fig. 5). DC-SIGN-ligation caused enhanced co-clustering of DC-
SIGN and CD150 in large platforms (after 5 mins, Fig. 5A, third
row), which subsequently protruded from the cell surface (after
10 mins, Fig. 5A, fourth row), revealing that DC-SIGN signaling
indeed promotes redistribution of CD150. Suggesting a role of
SMase activation in this process, DC-SIGN enriched protrusions
emanating from the cell surface (prominent formation of which may
relate to very low phospholipid scramblase levels of Raji cells [42])
were locally also enriched for ceramides (Fig. 5A, bottom row). As
reported erlier, efficient MV uptake into DCs relies on both DC-
SIGN (for trapping) and CD150 (particularly for fusion) [9,10]. In
line with earlier findings, interference of DC-SIGN interaction by
mannan, an antibody or EGTA reduced MV binding to DCs by
Figure 4. SMase activation enhances MV infection of DCs. A. Left panel: DCs were left untreated (black bar) or exposed to amitriptyline (white
bar) prior to MV infection. Right panel: An GFP-tagged MV was used for infection of DC cultures where expression of ASM had been siRNA silenced
(white bar) or not (black bar) (inset shows efficiency of silencing by RT-PCR). The frequency of cells expressing the MV N protein (left panel) or GFP
(right panel) was determined after 12 hrs by flow cytometry. Values shown were generated in each three independent experiments involving
different donors, p-values are indicated. B. DCs left untreated (each black bars and black lines) or pre-exposed to amitriptyline (each white bars and
grey lines) were exposed to MV and virus binding (after 2 hrs at 4uC, left panel and graph) or uptake (after 16 hrs at 37uC with FIP added following
infection) were determined by surface staining for F protein (to detect surface bound virus; left panels) or GFP detection (which is only expressed on
MV replication; right panels) by flow cytometry. The arrow marks the histogram for amitriptilyne treated cells. F protein expression or GFP
fluorescence in uninfected cells are shown as filled histogram. C. Molt-4 or A549 cells were left untreated (black bars) or pre-exposed to amitriptyline
prior to infection with Ed-eGFP (m.o.i. 2,5)(white bars). The percentage of GFP-expressing cells (left panel) and their mean fluorescent intensities (right
panel) are indicated. One out of three representative experiments is shown.
doi:10.1371/journal.ppat.1001290.g004
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approximately 50% ([9] and Fig. S1), and blocking of either DC-
SIGN and CD150 alone or in combination strongly interferes with
MV uptake and replication (Fig. 5B). On immature DCs, expression
of endogenous CD150 was generally low as reported [9,10], yet
increased surface display ligation within 15 mins after DC-SIGN
was detectable by flow cytometry (Fig. 5C). To follow CD150
redistribution in response to DC-SIGN ligation in DCs in detail, we
generated C-terminally HA-tagged CD150 which, when overex-
pressed in HeLa cells, did not differ with regard to subcellular
distribution, surface expression level, glycosylation and DRM
association from the unmodified protein (not shown). When
transfected into DCs (CD150-HA-DCs), transgenic CD150, similar
as the endogenous in DCs, mainly localized to intracellular
compartments, while DC-SIGN, expectedly appeared in clusters
at the cell surface [17,19,43] with little detectable overlap of both
molecules (Fig. 6A, upper panels and right graph). Mirroring our
findings in Raji-DC-SIGN cells, DC-SIGN ligation by mannan
promoted both surface translocation, clustering of CD150-HA and
co-clustering with DC-SIGN in DCs peaking between 10 and
15 mins after exposure (Fig. 6A, middle and bottom panels, and
right graph) indicating that DC-SIGN-signaling indeed causes
clustering and surface recruitment of this molecule. The latter was
further confirmed by using a surface biotinylation/streptavidin
precipitation approach with CD150-HA-DCs where exposure to
mannan substantially increased the amounts of CD150 pulled down
by streptavidin-beads (Fig. 6B, right lanes). The amounts of cytosolic
CD150 were also slightly elevated on mannan exposure indicating
that the CD150 storage compartment might reveal differential
sensitivity to detergent lysis on DC-SIGN signaling (Fig. 6B, left
lanes). DC-SIGN-dependent CD150-HA surface recruitment
involved transport and membrane fusion of exocytic vesicles in a
SNARE-dependent manner as indicated by its sensitivity to N-
ethylmaleimide (Fig. 6C), and, also ASM activation as it was
essentially abolished on pre-exposure to amitriptyline (Fig. 6D).
Figure 5. DC-SIGN ligation promotes surface redistribution of endogenous CD150. A. Raji (first row) or Raji-DC-SIGN cells (rows 2–5) were
left untreated (rows 1 and 2) or exposed to AZ-D1 (followed by crosslink) for 5 (row 3) or 10 mins (rows 4 and 5), fixed and stained for CD150 (rows 1–
4: green), DC-SIGN (rows 1–4: red, row 5: green) or ceramide (row 5: red). For this and the following experiments, colocalization coefficients were
determined using the Pearson’s algorithm (which ranges from 21 to +1, with values below 0,5 defined as no, between 0,5 and 0,75 as partial and
above as high level of co-localization) and are indicated within the panels. Size bars represent 5 mm. B. DCs were left untreated or pre-exposed to
mannan or a CD150-specific antibody (5C6) alone or in combination prior to infection with IC323-eGFP and subsequently cultured in the presence of
FIP. The mfi of GFP-expressing cells was determined after 24 hrs. C. Surface CD150 was detected on DCs by flow cytometry. DCs were left untreated
or exposed to mannan for 15 mins (upper panel, grey and black lines). The arrow marks mannan stimulated cells, the filled histogram shows the
isotype control. Bottom graph: CD150 surface expression fluctuation in response to mannan stimulation withinn 30 mins. as compared to constant
DC-SIGN levels. P,0,01.
doi:10.1371/journal.ppat.1001290.g005
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Importantly, ASM inhibition also interfered with MV-induced
CD150 surface recruitment as determined by WGA/CD150 co-
segregation levels (Fig. 7).
CD150 is co-transported with ASM to the cell surface
To gain insight into the nature of the translocating CD150
compartment, we performed marker analyses in DCs transfected
Figure 6. DC-SIGN ligation causes SMase dependent membrane redistribution of CD150 from intracellular compartments in DCs. A.
DC-SIGN and CD150-HA were co-detected in DCs left untreated (upper panels) or exposed to mannan for 10 or 15 mins (middle and bottom panels).
3D reconstructions of z-stacks are shown for each condition. Colocalization coefficients for DC-SIGN and CD150 were determined and are indicared in
the right graph (each 30 cells were recruited into the analysis). P = 0,01. B. CD150-HA transfected DCs were exposed to mannan or not, surface
biotinylated and analysed for plasma membrane accumulation of CD150 (upper panel) or DC-SIGN (bottom panel) after cell lysis and precipitation
using streptavidin beads (right lanes). Cytosolic detection of both proteins in lysates served as loading and transfection efficiency controls (left lanes).
* represents a non-specific signal. C. CD150-HA and wheat germ agglutinin (WGA) were co-detected in DCs left untreated (upper panels) or pre-
exposed for 15 mins to N-ethylmaleimide (NEM; bottom panels) or not prior to a 10 min. mannan treatment (middle panels). Colocalization
coefficients were determined and are indicated within the right panels (which shown representative pseudocoloured scatter plots) or, for each 30
cells analyzed, in the right bar graph with standard deviations indicated. P.0,01. D. DCs transfected to express CD150-HA for 5 hrs were exposed to
amitriptyline (right panels) or not (left panels) prior to mannan stimulation, fixed after the time intervals indicated (in mins) and stained for HA. Scale
bars represent 5 mm.
doi:10.1371/journal.ppat.1001290.g006
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to overexpress CD150-HA. Expectedly, CD150-HA was co-
detected with the trans-Golgi marker GM130 (Fig. 8A, upper
row). CD150-HA does not accumulate in the MIIC loading
compartment, as there is little co-segregation with oligomerized
MHCII (detected by the FN1 antibody) (Fig. 8A, second row), yet
rather in a Lamp-1 positive compartment that also contained
ASM (Fig. 8A, third row). CD150 substantially colocalized with
ASM in intracellular compartments in unstimulated DCs (Fig. 8B,
upper row, first three panels), and both were redistributed to the
cell surface on DC-SIGN ligation (Fig. 8B bottom row).
Confirming co-segration of both molecules, the degree of
colocalization remained identical prior to and after surface
recruitment (an example for unstimulated DCs is shown in the
pseudo-coloured scatter plot in Fig. 8B, upper row, right panel).
These data indicate that CD150 shares an intracytoplasmic
lysosomal compartment with ASM from which it is recruited to
and displayed at the cell surface on DC-SIGN-mediated ASM
activation to enhance MV entry into DCs.
Discussion
As professional antigen-presenting cells, DCs operate at the
interface of innate and adaptive immunity. Their location in the
mucosa coins them first cells encountering invading pathogens also
including viruses which, occasionally, exploit these cells as Trojan
horses for transfer to secondary lymphoid tissues. They display a
plethora of pattern recognition receptors (PRRs), and amongst
those, the C-type lectin receptor DC-SIGN containing a mannose-
binding domain has received particular attention with regard to its
extraordinary pathogen–recognition capability which involves a
broad panel of microorganisms and viruses also including HIV and
MV. This interaction, especially for viruses, does not promote
sorting into degradative compartments, but rather, DC-SIGN
mediated enhancement of DC cis-infection or trans-infection of T
cells have been described, and these involve enhanced access to the
DC cytoplasm (as for MV [9,10], or surface trapping of virions (as
for HIV and CMV [44,45,46]) whereby they are concentrated and
stored in invaginated compartments with plasma membrane
continuity for subsequent transfer to conjugating target cells. In
addition to these, signaling properties have been ascribed to DC-
SIGN, which, though not able to initiate signaling pathways leading
to regulated gene expression, modulates signals evoked after TLR
ligation to stimulate NF-kB activation, and Rho-GTPase dependent
activation of Raf-1 was found to be central [11,21,22].
SMase activation and subsequent ceramide accumulation were
directly linked to c-Raf-1 and ERK activation in response to DC-
SIGN ligation (Fig. 2B) and this in line with previous observations
made in other cell types. Thus, the ability of KSR1, identified as
essential component of the DC-SIGN signalosome [21] to activate
Raf-1 and to enhance its activity towards ERK1/2 requires
recruitment and specific binding to ceramide-enriched platforms
in Cos-7 and intestinal epithelial cells [33,34,35,36,37]. In
addition, Raf-1 activation in response to ceramide activation and
physical interaction of c-Raf-1 with ceramides in response to IL-1b
in mesangial cells were described [47,48]. Though our findings
with regard to the importance of DC-SIGN signal initiation are in
agreement with these observations, those elaborating on the role of
DC-SIGN modulation of TLR signaling are obviously not. As
shown by two independent methods, we were unable to confirm
an enhancing effect of DC-SIGN signaling on TLR-induced NF-
kB activation [11] using either antibodies (the ability of which to
promote c-Raf or ERK activation has been documented by us
(Fig. 2B) and others [11,22,41] or mannan at any time point
analysed (Fig. 3). The reasons for this discrepancy remain
unknown, yet are not likely to include donor dependent variations,
or any obvious technical problems since the reagents used gave
reliably the expected positive results in control experiments (e. g.
NF˜kB DNA binding and nuclear translocation in response to TLR
signaling alone (Fig. 3) or the ability of antibodies or mannan to
promote DC-SIGN activation (Figs. 2B)). Because abrogation of
SMase activation rather promoted LPS-induced NF˜kB activation,
our data suggest that DC-SIGN signaling may weaken rather than
enhance TLR4 signaling (Fig. 3 A,B), thereby downregulating
inflammatory responses. This hypothesis is in line with ASM
dependent downregulation of LPS-induced TNF-a production in
macrophages [49], and suggest that SMase activation in response
Figure 7. MV causes CD150 surface display in an amitriptyline sensitive manner. WGA and CD150 were codetected on CD150-DCs left
untreated (upper row) or exposed to MV with (bottom row) or without a 2 hrs amitriptyline pre-treatment (middle row). Colocalization coefficients
were determined (right intensity profiles) and are indicated for the examples shown within the panels, and for each 30 cells analyzed in the right
graph where they were scored into no (white bars), intermediate (grey bars) or high (black bars) degree of WGA/CD150 co-segregation.
doi:10.1371/journal.ppat.1001290.g007
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to a PRR such as DC-SIGN might be an efficient regulator of
systemic inflammatory responses.
SMase induction and subsequent membrane ceramide accu-
mulation on DC-SIGN ligation reveals a kinetics typically
observed for other receptors activating this pathway as well [27].
Both NSM and ASM are activated by DC-SIGN (Fig. 1C and D),
and interestingly, this, though DC-SIGN-independently, also
occurred in T cells exposed to MV [50] or on ligation of TNF-
R or IL-1b-R [51,52]. As evidenced from their kinetics of
induction and the ability of both amitriptyline and GW4896 to
interfere with DC-SIGN-dependent NF-kB modulation (Fig. 1
and 3B), NSM and ASM might be induced sequentially as
reported by us in T cells previously [50] which, was, however, not
further addressed in the present study. It is, however, tempting to
speculate that NSM activation might promote redistribution and
plasma membrane fusion of a lysosomal Lamp1+ compartment
containing both ASM and CD150 (Fig. 8) in an exocytic process
which, due to its NEM sensitivity, involves as yet unidentified
SNAREs (Fig. 6C).
Their activation by an established DC-SIGN agonist (and
sensitivity to EGTA inhibition) and cross-linked specific antibodies
clearly links SMases and ceramides to DC-SIGN ligation (Fig. 1).
MV is known to interact with other signaling surface receptors on
DCs which, theoretically, could also elicit these responses. CD46 is
Figure 8. ASM is co-transported with CD150 from lysosomal compartments upon DC-SIGN ligation. A. The HA-tag was co-stained in
CD150-HA transfected DCs with the cis-Golgi marker GM130 (upper panels), oligomerized MHC II class (FN1, second row), Lamp-1 (third row), and
ASM (bottom row) and analyzed by laser confocal microscopy. Intensity profiles and colocalization coefficients are shown for the examples selected
from a total of 30 cells analyzed in the right panels. B. CD150-HA expressing DCs were left untreated (upper panels 1–3) or stimulated with mannan
for 10 mins (bottom panels) and analyssed for HA-tag and ASM expression by confocal microscopy. The bottom right panel shows 3D reconstruction
of 20 z-stacks of mannan stimulated cell in the left panels, the upper right panel shows a representative profile example of CD150-HA/ASM
colocalization with the coefficient indicated. A unstimulated cell has been chosen, each 30 unstimulated and mannan exposed CD150-DCs were
recruited into the analysis.
doi:10.1371/journal.ppat.1001290.g008
DC-SIGN Mediated SMase Activation
PLoS Pathogens | www.plospathogens.org 9 February 2011 | Volume 7 | Issue 2 | e1001290
unlikely to be involved, since wild-type MVs as that used in this
study do not interact with this receptor [53]. MV binding to
CD150, which is expressed to low levels on DCs (Fig. 5B and
[9,10]), is not known to depend on divalent cations (neutralisation
of which abrogate ceramide induction by MV (Fig 1A)) nor do
antibodies directed against this molecule prevent their MV-
induced activation (Fig. 1A) indicating that CD150 also does not
contribute. MV is known to act as TLR2, but not TLR4 agonist
on monocytes, and LPS or PamCSK dependent upregulation of
CD150 has been proposed to support MV infection of these cells
[54,55]. Though LPS signaling in various cell types also including
DCs can involve ASM, this needs, however, tight regulation as it
results in massive DC apoptosis if high doses of LPS are applied
[56] or, on standard dose LPS application (100 ng/ml), if
ceramide turnover is prevented [57,58]. Ceramide generation,
however, is insufficient to promote most responses to LPS
including NF-kB activation [59], and in line with these
observations, DC-SIGN ligation alone does not activate NF-kB
[11] and SMase inhibition by amitriptyline did not interfere with
LPS-driven upregulation of CD83 and CD86 in our system as well
(Fig. 2A). Ligation of TLR2 by MV, not yet directly shown to
occur on DCs so far, is unlikely to contribute to early ASM
induction which is EGTA sensitive (Fig. 1), may, however,
contribute to late upregulation of CD150 (as measured in
monocytes late (12 or 24 hrs) after TLR2 stimulation [54,55])
coincided with that of proinflammatory cytokines and may thus
occur secondary to IL-1R ligation by IL-1b [7], a well established
SMase activator [51,60].
SMase activation as induced upon DC-SIGN ligation is
beneficial for MV uptake into DCs (Fig. 4), and this may also be
supported by biophysical properties of ceramide-enriched domains
such as promotion of negative membrane curvature which can
favor receptor mediated endocytosis [28,39], or their gel-like phase
supporting membrane fusion in general [27,40]. As these also
apply to SMase activators other than DC-SIGN, recruitment and
segregation of specific receptors into these platforms may be
decisive for their respective role in pathogen uptake. For MV, DC-
SIGN clearly enhances DC cis-infection [9,10], and this is greatly
aided by rapid surface recruitment of CD150 which co-clusters
with DC-SIGN. Thereby, SMase activation promotes surface
translocation and compartimentalization of a receptor promoting
MV fusion (Fig. 6 and 7). Interestingly, MV binding to DCs is not
strengthened on SMase activation (Fig. 4B) indicating that major
trapping of MV relies on DC-SIGN. This corroborates our earlier
observations that DC maturation (known to upregulate CD150
[9,10]) does not increase MV binding to these cells [61]. In line
with DC-SIGN acting as a major trapping factor for MV it is not
surprising that pre-ligation of this molecule by crosslinked DC-
SIGN antibodies or mannan blocks rather enhances MV uptake
into these cells because they render DC-SIGN inaccessible to MV
binding (Fig. 5B). Surface recruitment and compartimentalization
of CD150 may act in concert with the fusion promoting
membrane environment provided by SMase activation [40] to
support viral entry. If entry receptors are, however, highly
abundant (such as CD46 on Molt-4 or A549 cells), SMase
activation may not have substantial effects on viral uptake
(Fig. 4C). For HIV, however, ceramide induction elevation even
acts antivirally, since it shifted the virus into endocytic, degradative
uptake route in phagocytic cells, and prevented lateral co-
segregation of CD4 and CXCR4 and thereby membrane fusion
[62,63,64]. In DCs, where HIV is not routed into a degradative
compartment on DC-SIGN interaction, ceramide interference
with receptor co-segregation would be consistent with comparti-
mentalization and storage of virus for trans-infection of T cells
which is efficiently prevented on ablation of DC-SIGN interaction.
It will thus be interesting to determine if segregation of receptors
promoting uptake and routing of pathogens in response to SMase
activation in DCs by DC-SIGN and other stimuli follows a
common or counter-regulatory role which may essentially decide
the outcome of the interaction of a given pathogen with these cells.
Most interestingly, CD150 has recently been identified as
microbial sensor on macrophages essentially promoting phago-
some routing and recruitment of the cellular machinery for
bacterial killing [65]. If this would apply to DCs, upregulation of
CD150 in an SMase dependent manner might directly impact on
routing of pathogens other than MV in DCs.
Materials and Methods
Ethics statement
Primary human cells were obtained from the Department of
Transfusion Medicine, University of Wu¨rzburg, and analysed
anonymously. All experiments involving human material were
conducted according to the principles expressed in the Declaration
of Helsinki and ethically approved by the Ethical Committee of
the Medical Faculty of the University of Wu¨rzburg.
Cells and virus infection. Immature DCs were generated
from monocytes enriched from peripheral blood obtained from
healthy donors by Ficoll gradient centrifugation followed by plastic
adherence and subsequent culture in RPMI1640 containing 10%
FCS and human GM-CSF (500U/ml, Berlex, Germany)/IL-4
(250U/ml, Miltenyl Biotec, Germany) for 3 to 6 days. If not stated
otherwise, DCs were used immature for all experiments. B
lymphoblastoid Raji, Raji-DC-SIGN cells (kindly provided by T.
Geijtenbeek, Amsterdam) and Molt-4 cells were maintained in
RPMI1640/10% FCS, A549 cells in MEM 5% FCS. MV wild-type
strain WTF, the MV recombinants IC-323-eGFP (wild-type) (based
on the wild-type strain IC-323, kindly provided by Y. Yanagi,
Fukuoka), ED-eGFP (attenuated) (kindly provided by P. Duprex,
Belfast) and MGV (expressing VSV G protein instead of the MV
glycoproteins [66] (all grown on human lymphoblastoid BJAB cells
in RPMI1640/10% FCS) were titrated on marmoset lymphoblastoid
B95a cells (kept in RPMI1640/5%FCS). For exposure experiments,
MVs grown on BJAB cells were purified by sucrose gradient
ultracentrifugation as was the MOCK control from uninfected BJAB
cells. For binding experiments, DCs were exposed to MVs (if not
indicated otherwise, multiplicity of infection 2,5) for 2 hrs at 4uC. A
fusion inhibitory peptide (FIP) Z-D-Phe-L-Phe-Gly-OH (Bachem,
Heidelberg, Germany; 200 mM in DMSO) was included in these
and infection experiments a 2 hrs after exposure.
Ceramide/SMase detection. For surface detection of
ceramides and ASM we adopted an assay previously described
[67]. Briefly, cells (each 36105) were stimulated for the time
intervals indicated. a-DC-SIGN monoclonal antibody AZ-D1
(kindly provided by T. Geijtenbeek, Amsterdam) (1 mg/ml; if not
stated otherwise, pre-ligated for 15 mins on ice by 10 mg/ml gout-
a-mouse antibody), MOCK, MV or mannan (1mg/ml, Sigma
Aldrich) were used for DC stimulation. Cells were fixed in 1%
formaldehyde and incubated with a-ceramide IgM (clone MID
15B4, Alexis), a polyclonal rabbit a-ASM IgG (H-181; Santa Cruz)
over night at 4uC and washed extensively in PBS. Cell bound
antibody was desorbed for 30 sec with ice cold 100 mM glycine-
HCl, pH 2.5, and spotted onto nitrocellulose following
neutralisation with 100 mM Tris-HCl pH 8.0. Antibodies were
detected by goat-a-mouse IgM conjugated to peroxidase (Dianova,
Hamburg, Germany) and chemiluminescence was quantified using
AIDA software (Raytest, Straubenhardt, Germany). Alternatively,
cell surface ceramides were detected on fixed DCs using flow
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cytometry analysis after incubation with a-ceramide antibodies
(1:30 dilution) at 37uC for 1h and Alexa-488-conjugated secondary
a-mouse IgM (1:200 dilution, MolecularProbes) at 4uC for 30 mins.
Alternatively, ASM or NSM enzymatic activities were determined
using a commercial assay kit according to the manufacturers
instructions (Amplex Red Sphingomyelinase assay kit, Invitrogen).
Membrane enriched fractions were used for NSM activity detection
[27,40]. When indicated, the paired student’s t-test was used for
statistical analysis.
CD150 expression vector, siRNA tranfection and RT-PCR
analysis
CD150-HA was generated by PCR mediated HA-tag insertion
at the C-terminus of CD150 full-length cDNA and cloning under
CMV promoter in pCG vector. 15 mg of plasmid were
nucleofected into 26106 DCs following the manufacturer’s
protocol (Amaxa). For silencing of NSM2, DCs were transfected
with 100 nM siRNA targeting human SMPD3 (NSM2) specific
[68] or, for control, a scrambled siRNA (Eurogentec, Belgium)
using transfection reagent DF4 (Dharmacon, Lafayette, CO),
according to the manufacturer’s protocol. Before cells were
recruited into the respective experiments (after 72 hrs), aliquots
were harvested for RNA extraction (Qiagen, RNAeasy Kit) and
subsequent RT-PCR analyses. Forward 59-GCCCTTATCTTT-
CCATGCTACTG-39 and reverse 59-ACAGAGGCTGTCCT-
CTTAATGCT-39 primers were used for specific SMPD3
amplification.
Biotinylation, immunoprecipitation and Western blot
analysis. 36106 CD150-HA transfected DCs were stimulated
for 15 mins with 1mg/ml mannan, washed twice with ice cold
PBS, pH 8.0 and rotated with 0,5 mg/ml Sulfo-NHS-LC-Biotin
(Pierce) for 30 mins at room temperature, washed with PBS,
100 mM Glycin, pH 7,0 and lysed in buffer containg 1% Triton-
X 100. Biotinylated surface proteins were precipitated using
streptavidin beads (Pierce) overnight at 4uC and subjected to
Western blot analysis for CD150 and DC-SIGN expression using
rabbit polyclonal antibodies directed against the HA-tag (Y-11) or
DC-SIGN (H-200, both Santa Cruz).
Extracts isolated from phorbolester/ionomycin (PMA 40ng/ml,
ionomycin 2,5 mM, Sigma Aldrich) or a-DC-SIGN activated DC
cultures were harvested and analysed using antibodies directed
against p-c-Raf-1 (Ser338), ERK, and pERK (Thr202/Tyr204)
(Cell Signalling, Frankfurt, Germany) in Western blot. When
indicated, chemiluminescence was quantified using the AIDA
software program (Raytest, Straubenhardt, Germany).
NF˜kB activation assays. DNA binding activity of NF-kB
p65 was determined with ELISA based TransAM NF-kB family
kit (Active Motif, Carlsbad, CA), according to the manufacturer’s
protocol. Experiments were repeated three times using cells of
different donors.
Flow cytometry and immunostaining. Cell surface levels
of ceramides, CD83, CD86 and CD150 were detected by flow
cytometry by staining with antibodies specific for ceramides (clone
MID 15B4, Alexis), CD83 and CD86 (BD Biosciences
Pharmingen), CD150 (5C6). Intracellular levels of MV N
protein were determined using a specific antibody (F227,
generated in our laboratory). Alternatively, GFP was detected in
cells infected with IC-323-eGFP or ED-eGFP. For immunostaining,
DCs (when indicated pre-exposed for 2 hrs to amitriptyline
(10 mM), GW4869 (1,3 mM), or 15 mins to N-ethylmaleimide
(NEM, 1mM) (all Sigma-Aldrich, Taufkirchen, Germany) were
transferred onto 8-chamber slides (LabTekII, Nunc, Wiesbaden,
Germany) pre-coated with poly-L-lysine and subsequently activated
by LPS (100 ng/ml), mannan (1mg/ml), DC-SIGN-specific
polyclonal antibody H200 (Santa Cruz) or mannan for the time
intervals indicated at 37uC. For immunostaining, cells were fixed in
paraformaldehyde (4% in PBS) and stained for membrane ceramide
(cloneMID 15B4, Alexis) or, after permeabilisation (0.1%Triton X-
100) for CD150 (clone IPO-3, Abcam), oligomerised MHC class II
(FN-1; kindly provided by Steinar Funderud), Lamp-1 (rabbit
polyclonal serum; kindly provided by Soren Carlsson, Umea,
Sweden), p65 (C22B4, Cell Signalling, Frankfurt, Germany), wheat
germ agglutinin or ASM (H181, Santa Cruz). Actin was detected
using Alexa 594 conjugated phalloidin (Molecular Probes,
Karlsruhe, Germany), DAPI was used to stain nuclei.
Fluorochrome G (Southern Biotech, Eching, Germany) mounted
samples were analysed by confocal laser scanning microscopy (Laser
Scan Microscope, LSM510 Meta, Software version 3.2, SP2;
Axiovert 200M microscope, Objective: 636; aperture 1.4 plan
apochromat; when indicated, vertical z-stacks were acquired (20
optical planes) and 3D deconvolutions were performed (by using
Zeiss software). When indicated, colocalization coefficients were
determined using the Pearson’s algorithm (which ranges from21 to
+1, with values below 0,5 defined as no, between 0,5 and 0,75 as
partial and above as high level of co-localization). The pseudo-
coloured scatter plots shown display frequencies of the red-green
pixels in the original images. Hot colours resresent high values of
colocalization.
Supporting Information
Figure S1 DC-SIGN blocking interferes with MV binding to
DCs. DCs were pretreated with mannan at the concentrations
indicated, a DC-SIGN-specific antibody (H200) (10 mg/ml) or
10 mM EGTA prior to MV exposure (m.o.i. 2). Percentages of
cells staining for MV F protein and mfis were determined by flow
cytometry following a 1hrs incubation period on ice.
Found at: doi:10.1371/journal.ppat.1001290.s001 (0.45 MB
EPS)
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